NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting
NexImmune, Inc. (NEXI)
Company Research
Source: GlobeNewswire
GAITHERSBURG, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today announced that two abstracts have been accepted for poster presentation at the upcoming Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting in Washington, D.C., being held November 10-14, 2021. Poster Presentation: Title: High throughput screening of HPV-antigen peptides and expansion of tumor-specific T cells for adoptive cell therapy of HPV-associated malignanciesAbstract Number: 97Authors: David Langan, PhD; Jourdain Lemaster; Lauren Suarez, PhD; Pratima Kunwar, PhD; Sojung Kim, PhD; Mathias Oelke, PhDDate & Time: Friday, November 12, 2021; Poster Hall Hours: 7 am–8:30 pm EST Title: In vivo and in vitro characterization of AIM ACT, a novel nanoparticle-based technology, expanded MART-1 sp
Show less
Read more
Impact Snapshot
Event Time:
NEXI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEXI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEXI alerts
High impacting NexImmune, Inc. news events
Weekly update
A roundup of the hottest topics
NEXI
News
- NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]Yahoo! Finance
- NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewswire
- NexImmune slips after securities offering [Seeking Alpha]Seeking Alpha
- NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules [Yahoo! Finance]Yahoo! Finance
- NexImmune Announces $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesGlobeNewswire
NEXI
Sec Filings
- 4/16/24 - Form 10-K
- 4/10/24 - Form 3
- 4/5/24 - Form 8-K
- NEXI's page on the SEC website